Assignee
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD
CN·125 granted patents·97 pending applications·163 citations·filing 2012–2025
Top patents by PatentIndex Score
222 records- 0192US9725439B2Quinazoline derivative and preparation method thereforCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2014·Granted Aug 8, 2017·13 cites·16 claims
- 0291US10307412B2Quinoline derivative against non-small cell lung cancerCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2015·Granted Jun 4, 2019·6 cites·16 claims
- 0391US9968597B2Methods and uses of quinoline derivatives in the treatment of soft tissue sarcomas and pharmaceutical compositions for treatment of sameCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2015·Granted May 15, 2018·13 cites·20 claims
- 0491US9969719B2Substituted 2-hydrogen-pyrazole derivative serving as anticancer drugCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2016·Granted May 15, 2018·9 cites·15 claims
- 0591US9962388B2Pyrrolopyrimidine compounds used as TLR7 agonistCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2015·Granted May 8, 2018·14 cites·10 claims
- 0689US10183017B2Methods and uses of quinoline derivatives in the treatment of soft tissue sarcomas and pharmaceutical compositions for treatment of sameCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2018·Granted Jan 22, 2019·9 cites·20 claims
- 0788US11597716B2N-heterocyclic five-membered ring-containing capsid protein assembly inhibitor, pharmaceutical composition thereof, and use thereofCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2019·Granted Mar 7, 2023·5 cites·20 claims
- 0888US11419862B2Quinoline derivative for treatment of nasopharyngeal carcinomaCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2020·Granted Aug 23, 2022·3 cites·22 claims
- 0988US10888559B2Quinoline derivatives for non-small cell lung cancerCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2019·Granted Jan 12, 2021·3 cites·18 claims
- 1086US10736887B2Quinoline derivative for treating gastric cancerCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2017·Granted Aug 11, 2020·3 cites·13 claims
- 1186US10251876B2Method for treating tumour, pharmaceutical composition and medicinal kitCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2015·Granted Apr 9, 2019·7 cites·15 claims
- 1285US12319689B2Methyl- and trifluoromethyl-containing disubstituted sulfonamide selective BCL-2 inhibitorCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2020·Granted Jun 3, 2025·2 cites·20 claims
- 1385US11731955B2Crystal habit of quinoline derivative and preparation method for crystalline powder thereofCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2019·Granted Aug 22, 2023·3 cites·18 claims
- 1485US11554115B2Quinoline derivative for treatment of triple-negative breast cancerCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2019·Granted Jan 17, 2023·2 cites·20 claims
- 1585US10875888B2Steroid derivative FXR agonistCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2017·Granted Dec 29, 2020·3 cites·20 claims
- 1684US10562904B2Synthesis process of ruxolitinibCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2016·Granted Feb 18, 2020·8 cites·20 claims
- 1783US11091460B2Syk inhibitor and use method thereforCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2018·Granted Aug 17, 2021·3 cites·20 claims
- 1883US10766901B2Preparation method for chiral pyrrolopyrimidine compoundCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2017·Granted Sep 8, 2020·3 cites·20 claims
- 1982US11459337B2Isothiazolo[5,4-D]pyrimidine compound as IRAK4 inhibitorCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2019·Granted Oct 4, 2022·2 cites·20 claims
- 2081US11332465B2Diarylthiohydantoin compound as androgen receptor antagonistCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2018·Granted May 17, 2022·3 cites·20 claims
- 2181US10376512B1Crystal of aniline pyrimidine compound of trifluoroethyl substituted indole and salt thereofCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2018·Granted Aug 13, 2019·2 cites·14 claims
- 2280US12054482B2TLR8 agonistCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2019·Granted Aug 6, 2024·1 cites·11 claims
- 2379US11358950B2SMAC mimetics used as IAP inhibitors and use thereofCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2018·Granted Jun 14, 2022·2 cites·19 claims
- 2479US10745383B21,3,5-triazine derivative and method of using sameCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2016·Granted Aug 18, 2020·2 cites·15 claims
- 2579US10626107B2Crystal form, salt type of substituted 2-hydro-pyrazole derivative and preparation method thereforCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2017·Granted Apr 21, 2020·2 cites·16 claims
- 2679US10561647B2Use of quinoline derivatives for treating oesophageal cancer and treatment method, pharmaceutical composition and kit thereofCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2017·Granted Feb 18, 2020·3 cites·15 claims
- 2779US9856256B2Pyridino[1,2-A]pyrimidone analogue used as P13K inhibitorCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2015·Granted Jan 2, 2018·3 cites·16 claims
- 2878US10555949B2Pyrrolopyrimidine compounds used as TLR7 agonistCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2018·Granted Feb 11, 2020·2 cites·14 claims
- 2977US11993596B2Fused tri-cyclic compound as PDE3/PDE4 dual inhibitorCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2019·Granted May 28, 2024·1 cites·21 claims
- 3075US9206192B2Trolox derivative-modified fat-soluble anti-cancer pharmaceutical compounds, preparations, preparing methods and use thereofCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2012·Granted Dec 8, 2015·1 cites·7 claims
- 3175US2024052032A1Anti-lag-3 antibodies and compositionsCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2023·Application pending·0 cites
- 3273US12390458B2Therapeutic combination of quinoline derivative and antibodyCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2019·Granted Aug 19, 2025·1 cites·14 claims
- 3373US11834503B2Anti-lag-3 antibodies and compositionsCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2022·Granted Dec 5, 2023·0 cites·20 claims
- 3473US11014943B2Azetidine derivativeCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2018·Granted May 25, 2021·1 cites·20 claims
- 3573US9708295B2Substituted 2-aminopyridine protein kinase inhibitorCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2014·Granted Jul 18, 2017·3 cites·17 claims
- 3673US2024294526A1Fused tri-cyclic compound as a pde3/pde4 dual inhibitorCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2024·Application pending·0 cites
- 3772US12221432B2Estrogen receptor antagonistCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2019·Granted Feb 11, 2025·1 cites·20 claims
- 3871US12116356B2N-heterocyclic five-membered ring-containing capsid protein assembly inhibitor, pharmaceutical composition thereof, and use thereofCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2023·Granted Oct 15, 2024·0 cites·20 claims
- 3970US12263172B2Toll-like receptor agonists for use in the treatment of hepatitis bCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2020·Granted Apr 1, 2025·1 cites·20 claims
- 4070US10981860B2Caspase inhibitor and pharmaceutical composition, use and therapeutic method thereofCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2017·Granted Apr 20, 2021·1 cites·18 claims
- 4170US10570141B2Substituted pyrrolopyrimidine CDK inhibitor, pharmaceutical composition containing same and use thereofCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2017·Granted Feb 25, 2020·1 cites·20 claims
- 4270US10231973B2Salts of quinazoline derivative and method for preparing the sameCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2016·Granted Mar 19, 2019·1 cites·14 claims
- 4370US2025367187A1Quinoline derivative used for treating small cell lung cancerCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2025·Application pending·0 cites
- 4467US10035792B2Resorcinol derivative as HSP90 inhibitorCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2016·Granted Jul 31, 2018·1 cites·20 claims
- 4567US9981946B2Pyridine-substituted 2-aminopyridine protein kinase inhibitorsCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2015·Granted May 29, 2018·1 cites·20 claims
- 4666US11866433B2Diarylthiohydantoin compound as androgen receptor antagonistCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2021·Granted Jan 9, 2024·0 cites·20 claims
- 4764US11773079B2Crystalline forms of 4-(tert-butoxyamino)-6-(6-(trifluoromethyl)pyridin-2-yl)-N-(2-(trifluoromethyl)pyridin-4-yl)-1,3,5-triazin-2-amineCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2021·Granted Oct 3, 2023·0 cites·12 claims
- 4864US11534398B2Inhaled preparation of isoglycyrrhizic acid or salt thereof, and use in preparing drugs for treating respiratory system diseasesCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2020·Granted Dec 27, 2022·0 cites·10 claims
- 4964US10717753B2Deuterium-modified brigatinib derivatives, pharmaceutical compositions comprising same, and use thereofCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2016·Granted Jul 21, 2020·1 cites·10 claims
- 5064US2026098037A1Compound containing multi-fused ring structureCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2025·Application pending·0 cites
Showing the top 50 of 222 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →